Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
American Journal of Obstetrics and Gynecology 2020-Apr

Vaginal bleeding and nausea in early pregnancy as predictors of clinical pregnancy loss.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Länken sparas på Urklipp
Elizabeth DeVilbiss
Ashley Naimi
Sunni Mumford
Neil Perkins
Lindsey Sjaarda
Jessica Zolton
Robert Silver
Enrique Schisterman

Nyckelord

Abstrakt

While nausea and vaginal bleeding are commonly experienced in early pregnancy, their prognostic value in predicting clinical pregnancy loss is not well understood.To understand whether timing of bleeding and nausea symptoms can be used to predict risk of pregnancy loss among women with ultrasound confirmed pregnancies.A cohort of 701 women with clinically confirmed pregnancies and 1-2 prior pregnancy losses were preconceptionally enrolled in the EAGeR trial (2006-2012). Participants completed daily symptom diaries from 2 to 8 weeks' gestation and were prospectively followed for detection of pregnancy loss. The risk of pregnancy loss was estimated for each observed bleeding and nausea pattern, and positive and negative predictive values for each pattern were calculated.Among 701 women, 38% reported any vaginal bleeding and 92% reported any nausea. Most bleeding was spotting and contained within a single episode. Vaginal bleeding occurred in 16% (16% live birth, 16% clinical loss), 15% (15% live birth, 20% clinical loss), and 21% (19% live birth, 33% clinical loss) of women within weeks 2-4, 4-6, and 6-8, respectively. Nausea was reported in 33% (34% live birth, 29% clinical loss), 66% (68% live birth, 60% clinical loss), and 87% (91% live birth, 69% clinical loss) of women within these respective epochs. Bleeding in the absence of nausea at 6-8 weeks' gestation (3.6% prevalence) had the greatest risk of clinical loss (RD = 56%, 95% CI [38, 75]), a positive predictive value of 68% [50, 86], negative predictive value of 86% [83, 88], positive likelihood ratio of 11 [2.0, 20], and negative likelihood ratio of 0.86 [0.79, 0.93]. This symptom pattern predicted clinical pregnancy loss similar to (AUC = 0.85 [0.82, 0.90]) age, BMI, blood pressure, and waist to hip ratio (AUC = 0.81 [0.78, 0.88]) measured preconceptionally.Women experiencing bleeding 6-8 weeks' gestation without accompanying nausea had an elevated risk of clinical pregnancy loss. Bleeding or nausea prior to 6 weeks' gestation were not predictive of risk of clinical loss.

Gå med på vår
facebook-sida

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

  • Fungerar på 55 språk
  • Växtbaserade botemedel som stöds av vetenskap
  • Örter igenkänning av bild
  • Interaktiv GPS-karta - märka örter på plats (kommer snart)
  • Läs vetenskapliga publikationer relaterade till din sökning
  • Sök efter medicinska örter efter deras effekter
  • Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

Google Play badgeApp Store badge